GLUTOSIN Trademark

Trademark Overview

On Monday, October 22, 2012, a trademark application was filed for GLUTOSIN with the United States Patent and Trademark Office. The USPTO has given the GLUTOSIN trademark a serial number of 79127808. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, October 23, 2022. This trademark is owned by SCIOTEC Diagnostic Technologies GmbH. The GLUTOSIN trademark is filed in the Pharmaceutical Products category with the following description:

Dietetic preparations and substances adapted for medical use, namely, dietary supplements; nutritional supplements; pharmaceutical preparations for the treatment of gluten intolerance; chemico-pharmaceutical preparations for the treatment of gluten intolerance; sanitary preparations for medical use; biological preparations for medical purposes for the treatment of gluten intolerance; chemical preparations for medical purposes for the treatment of gluten intolerance; ferments for medical use
glutosin

General Information

Serial Number79127808
Word MarkGLUTOSIN
Filing DateMonday, October 22, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, October 23, 2022
Registration Number4412858
Registration DateTuesday, October 8, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2013

Trademark Statements

Goods and ServicesDietetic preparations and substances adapted for medical use, namely, dietary supplements; nutritional supplements; pharmaceutical preparations for the treatment of gluten intolerance; chemico-pharmaceutical preparations for the treatment of gluten intolerance; sanitary preparations for medical use; biological preparations for medical purposes for the treatment of gluten intolerance; chemical preparations for medical purposes for the treatment of gluten intolerance; ferments for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTADA Arzneimittel AG
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressDE
Party NameSCIOTEC Diagnostic Technologies GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAT
Party NameSCIOTEC Diagnostic Technologies GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAT
Party NameSCIOTEC Diagnostic Technologies GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAT

Trademark Events

Event DateEvent Description
Monday, May 15, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, May 15, 2023DEATH OF INTERNATIONAL REGISTRATION
Sunday, March 6, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, February 4, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, February 4, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 26, 2021CANCELLED SECTION 71
Monday, October 8, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, December 29, 2016CHANGE OF OWNER RECEIVED FROM IB
Thursday, July 28, 2016NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 22, 2014NEW REPRESENTATIVE AT IB RECEIVED
Monday, May 19, 2014CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Thursday, May 8, 2014CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, March 13, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, February 3, 2014FINAL DISPOSITION NOTICE SENT TO IB
Monday, February 3, 2014FINAL DISPOSITION PROCESSED
Wednesday, January 8, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 8, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, July 23, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 14, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 13, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 10, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 10, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 4, 2013ASSIGNED TO LIE
Friday, May 31, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 31, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 31, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 15, 2013REFUSAL PROCESSED BY IB
Wednesday, April 24, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 24, 2013REFUSAL PROCESSED BY MPU
Wednesday, April 24, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 23, 2013NON-FINAL ACTION WRITTEN
Friday, April 19, 2013APPLICATION FILING RECEIPT MAILED
Monday, April 15, 2013ASSIGNED TO EXAMINER
Monday, April 15, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 12, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 11, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

glutosin preparations medical gluten treatment intolerance purposes supplements pharmaceutical biological substances